Vascular endothelial growth factor (VEGF) in serum and exhaled breath condensate (EBC) of subjects with non-small cell lung cancer (NSCLC)

C. Montero-Martínez, L. Núñez-Naveira, R. Fraga-Iriso, L. A. Mariñas-Pardo, A. Souto Alonso, N. Brienza, H. Verea, D. Ramos-Barbón (A Coruña, Spain)

Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Session: Diagnosis and prognosis in thoracic oncology
Session type: Oral Presentation
Number: 1276
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Montero-Martínez, L. Núñez-Naveira, R. Fraga-Iriso, L. A. Mariñas-Pardo, A. Souto Alonso, N. Brienza, H. Verea, D. Ramos-Barbón (A Coruña, Spain). Vascular endothelial growth factor (VEGF) in serum and exhaled breath condensate (EBC) of subjects with non-small cell lung cancer (NSCLC). Eur Respir J 2007; 30: Suppl. 51, 1276

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Vascular endothelial growth factor (VEGF) in serum and exhaled breath condensate (EBC) as a potential biomarker for early detection of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008

Tumor size and inflammatory cytokines in exhaled breath condensate in patients with non small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012


Pretreatment levels of VEGF and 8-isoprostane in exhaled breath condensate (EBC) and serum of lung cancer patients
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008


LATE-BREAKING ABSTRACT: Expression of macrophage migration inhibitory factor (MIF) in the serum and lung tissues in patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002

Heterogeneous reactivity of ICAM-1 on alveolar macrophages (AMs) in patients with non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003

Vascular endothelial growth factor in sera of patients with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 330s
Year: 2005

Pre-operative levels of serum vascular endothelial growth factor A (VEGF-A), C (VEGF-C) and D (VEGF-D) in non-small cell lung cancer (NSCLC). Preliminary report
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006

Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Risk factor for survival in never-smokers non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010

The prognostic value of serum epidermal growth factor receptor (EGFR) levels in patients with non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 674s
Year: 2004

Espression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1-Flt1, VEGF-R2-Flk1) in non small cell (NSCLC) and small cell lung carcinomas (SCLC). Correlation with clinical outcome
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008


Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007


Vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1-Flt-1, VEGF-R2-KDR/Flk-1) as prognostic indicators in small cell lung carcinomas (SCLC)
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Increased vascular-endothelial growth factor a (VEGF-A) expression and response to angiogenesis inhibitor erlotinib in non-small-cell lung cancer (NSCLC) – hint for a new predictive marker?
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


Protein markers in the exhaled breath condensate of lung carcinoma patients
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012

Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009


Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


The prognostic significance of sVEGF levels in patients(pts) with Non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 363s
Year: 2003